NCT01571973UnknownNot Applicable
EVALUATION OF THE EFFECTIVENESS OF PHARMACEUTICAL CARE (DÁDER PROGRAM) IN DEPRESSED OUTPATIENTS TREATED WITH PSYCHOTROPIC
Federal University of São Paulo0 sites60 target enrollmentStarted: March 1, 2010Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Enrollment
- 60
- Primary Endpoint
- depression level
Study Overview
Brief Summary
The study examines whether pharmacotherapeutic follow-up improves outcomes of treatment of depressed outpatients.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Supportive Care
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 65 Years (Adult, Older Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •women between 18 and 65 years, with diagnostic hypothesis of depression at the beginning of treatment or change in treatment unless 2 months (dosage or substance)
Exclusion Criteria
- •record of dependence on psychoactive substances, diagnosed schizophrenia,
- •low education (illiterate) or cognitive impairment evident that compromise the completion of research instruments
Outcomes
Primary Outcomes
depression level
Time Frame: six months
evaluation depression level by Beck scale
Secondary Outcomes
- anxiety level(6 months)
- compliance(6 months)
Investigators
Ana Regina Noto
Ph.D.
Federal University of São Paulo
Similar Trials
Completed
Not Applicable
Effectiveness of the follow-up of depressed patients by nursesMajor depressionMental and Behavioural DisordersISRCTN08808171Jordi Gol i Gurina Primary Care Research Institute (IDIAP Jordi Gol i Gurina) (Spain)460
Unknown
Phase 2
Myofascial Pain Patients' Response to the Administration of Low Doses of Amitriptyline and Citalopram Compared With the Use of Bite SplintMuscle Type Temporomandibular DisordersMyofascial Pain of the Masticatory MusclesNCT04777838University of Coimbra80
Completed
Phase 4
Pharmacological Intervention in Depression After Traumatic Brain InjuryTBI (Traumatic Brain Injury)NCT00205491Virginia Commonwealth University100
Unknown
Phase 4
Accurate Clinical Study of Medication in Patients With Depression Via Pharmacogenomics (PGx) and Therapeutic Drug Monitoring (TDM) of VenlafaxineDepressionNCT04207385Xijing Hospital160
Terminated
Phase 4
Effectiveness of Nimodipine Plus Antidepressant Medication in Treating Vascular DepressionDepressionNCT00781326University of Pittsburgh9